ATE227985T1 - Konzentrat für medizinische lösung und dessen verwendung - Google Patents

Konzentrat für medizinische lösung und dessen verwendung

Info

Publication number
ATE227985T1
ATE227985T1 AT98948026T AT98948026T ATE227985T1 AT E227985 T1 ATE227985 T1 AT E227985T1 AT 98948026 T AT98948026 T AT 98948026T AT 98948026 T AT98948026 T AT 98948026T AT E227985 T1 ATE227985 T1 AT E227985T1
Authority
AT
Austria
Prior art keywords
concentrate
medical solution
glucose
concentration
gluconic acid
Prior art date
Application number
AT98948026T
Other languages
English (en)
Inventor
Torbjoern Linden
Lennart Joensson
Stefan Knutsson
Robert Picard
Original Assignee
Gambro Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gambro Ab filed Critical Gambro Ab
Application granted granted Critical
Publication of ATE227985T1 publication Critical patent/ATE227985T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98948026T 1997-10-07 1998-10-05 Konzentrat für medizinische lösung und dessen verwendung ATE227985T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9703650A SE510587C2 (sv) 1997-10-07 1997-10-07 Koncentrat för dialyslösning och användning därav
PCT/SE1998/001785 WO1999017762A1 (en) 1997-10-07 1998-10-05 Concentrate for medical solution and use thereof

Publications (1)

Publication Number Publication Date
ATE227985T1 true ATE227985T1 (de) 2002-12-15

Family

ID=20408531

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98948026T ATE227985T1 (de) 1997-10-07 1998-10-05 Konzentrat für medizinische lösung und dessen verwendung

Country Status (9)

Country Link
US (1) US6323182B1 (de)
EP (1) EP1033984B1 (de)
JP (1) JP4346818B2 (de)
AT (1) ATE227985T1 (de)
AU (1) AU9468998A (de)
DE (1) DE69809587T2 (de)
ES (1) ES2183417T3 (de)
SE (1) SE510587C2 (de)
WO (1) WO1999017762A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60039978D1 (de) 1999-04-26 2008-10-02 Edwards Lifesciences Ag Substitutions-infusionflüssigkeit und zitratanticoagulation
US8105258B2 (en) 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
US7186420B2 (en) 1999-04-26 2007-03-06 Edwards Lifesciences Corporation Multi-part substitution infusion fluids and matching anticoagulants
US7445801B2 (en) * 2002-06-07 2008-11-04 Baxter International Inc. Stable bicarbonate-based solution in a single container
GR1004476B (el) * 2002-12-12 2004-03-05 Ιπποκρατης Αλεξανδρου Γιατζιδης Γλουκονικο οξυ. ενας νεος ισχυρος και ακινδυνος δεσμευτης για τη διορθωση της υπερφωσφαταιμιας των αρρωστων με τελικη νεφρικη ανεπαρκεια
US20040121982A1 (en) * 2002-12-20 2004-06-24 Leo Martis Biocompatible dialysis fluids containing icodextrins
US20050276868A1 (en) * 2004-06-10 2005-12-15 Bart Degreve Bicarbonate-based peritoneal dialysis solutions
US20100247694A1 (en) * 2008-01-31 2010-09-30 Joseph Di Bartolomeo Composition and method for treament of inflamation and infections of the outer ear canal, nose and paranasal sinuses
US20100051552A1 (en) 2008-08-28 2010-03-04 Baxter International Inc. In-line sensors for dialysis applications
DE102010039489A1 (de) * 2010-08-18 2012-02-23 Fresenius Medical Care Deutschland Gmbh Konzentrat
JP5282923B2 (ja) * 2011-12-06 2013-09-04 富田製薬株式会社 重炭酸透析剤
CN111432857A (zh) * 2017-05-05 2020-07-17 费森尤斯医疗护理德国有限责任公司 腹膜透析浓缩物、腹膜透析袋和用于连续非卧床腹膜透析或自动腹膜透析的套件
CN114460202A (zh) * 2022-02-11 2022-05-10 山东威高肾科医疗器械有限公司 一种血液透析液中葡萄糖浓度的检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784495A (en) 1987-02-06 1988-11-15 Gambro Ab System for preparing a fluid intended for a medical procedure by mixing at least one concentrate in powder form with water
ES2056497T3 (es) * 1990-01-12 1994-10-01 Nephro Medica Pharma Solucion para infusion y dialisis que contiene bicarbonato y calcio.
EP0752243B1 (de) * 1991-04-26 2003-03-12 Mitsubishi Pharma Corporation Mit flüssigen Infusionen gefüllte Behälter
ES2149793T5 (es) 1993-02-19 2005-03-01 Wilfried Dr.-Ing. Schal Procedimiento para la preparacion de liquido dializador bicarbonatado para la hemodialisis.
IT1263967B (it) * 1993-02-24 1996-09-05 Soluzioni per dialisi peritoneale
KR960000223A (ko) * 1994-06-08 1996-01-25 김정순 신규한 피리돈 카르복실산 화합물을 함유한 수용액 및 이의 제조방법
DE19631124A1 (de) * 1996-08-01 1998-02-05 Fresenius Medical Care De Gmbh Verfahren zur Herstellung einer Bicarbonat enthaltenden Infusions- oder Dialysierlösung

Also Published As

Publication number Publication date
JP4346818B2 (ja) 2009-10-21
DE69809587D1 (de) 2003-01-02
SE9703650L (sv) 1999-04-08
EP1033984A1 (de) 2000-09-13
WO1999017762A1 (en) 1999-04-15
ES2183417T3 (es) 2003-03-16
SE9703650D0 (sv) 1997-10-07
EP1033984B1 (de) 2002-11-20
JP2001518497A (ja) 2001-10-16
DE69809587T2 (de) 2003-03-27
SE510587C2 (sv) 1999-06-07
US6323182B1 (en) 2001-11-27
AU9468998A (en) 1999-04-27

Similar Documents

Publication Publication Date Title
ATE227985T1 (de) Konzentrat für medizinische lösung und dessen verwendung
DE59812766D1 (de) Lösung für die Peritonealdialyse
Orena et al. Binding and uptake of copper from ceruloplasmin
ATE380559T1 (de) Konjugate enthaltend ein antitumorales mittel und deren verwendung
NO871341D0 (no) Overflateaktive polykarbodiimider og dispersjoner derav.
BR9506021A (pt) Solução de diálise peritoneal e processo para corrigir a acidose metabólica
ATE114319T1 (de) Produktion von proteinen in aktiven formen.
ATE259644T1 (de) Behandlung von hämoglobin enthaltenden erythrozyten mit stickstoffoxyd
DE69727811D1 (de) Verwendung einer glukosehaltigen lösung in der peritonealdialyse mit verminderter bildung von zersetzungsprodukten
TW337997B (en) Pharmaceutical preparation containing plasminogen activators
EP1106150A3 (de) Wegwerfwindel
EE9800066A (et) Erütropoetiini ja rauapreparaatide kasutamine farmatseutilise liitpreparaadi valmistamiseks, farmatseutiline ühispakend ja meetod rauaseisundi määramiseks kehavedelike proovis
DE69417397D1 (de) Lösung, die igf-1 enthält
ATE55389T1 (de) 99mtc(iii)-agenzien zur myokardialen darstellung, in vivo nichtreduzierbar.
FI881123A0 (fi) Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar.
ES2060057T3 (es) Soluciones acuosas conteniendo proteina.
ATE150309T1 (de) Intravenös verabreichbare wässrige lösung von sulfametrol und trimethoprim
Gahr et al. Haemolytic Anaemia due to Glucose‐6‐Phosphate Dehydrogenase (G6PD) Deficiency: Demonstration of Two New Biochemical Variants, G6PD Hamm and G6PD Tarsus
TR200001187T2 (tr) Fizyolojik olarak uygun sıvı solüsyonlar ve kullanım metotları
Glezer et al. Side effects of hypothiazide therapy of arterial hypertension.
UA25289A (uk) Спосіб приготуваhhя горілки "імператорська"
DK1318821T3 (da) Væske til hæmofiltrering
Arai Long-Term Oxygen Therapy Domiciliary or In-Hospital?
Villegas-Navarro et al. Anthracene-9-carboxylic acid and haematological and biochemical variables in the rat
Yuecel et al. Increased susceptibility to oxidative stress in lens tissues of sulfur dioxide exposed rats

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties